CEO Bent U. Frandsen will present ExpreS2ion to investors and potential investors. Registration is possible via BioStock website.

Meet ExpreS2ion’s VP of Preclinical Development, Dr. Mette Thorn, and hear the company’s preclinical development partners from the University of […]

An opportunity for investors and potential partners to meet ExpreS2ion CEO Bent U. Frandsen and CFO Keith Alexander in 1-on-1 […]

ExpreS2ion CEO, Bent U. Frandsen and CFO Keith Alexander will discuss the Q2 2022 results and answer investors’ questions. More […]

Meet ExpreS2ion CEO, Bent Frandsen, at the largest global biotechnology industry event. More information and registration can be found on […]

Meet our scientists at the leading conference focused on the discovery, development and manufacture of vaccines, hosted by ECI. More […]

ExpreS2ion CEO Bent U. Frandsen will discuss the Q1 2022 results and answer investors’ questions. More information and registration can […]

ExpreS2ion VP of Preclinical Development Mette Thorn and CFO Keith Alexander will provide an update on ExpreS2ion’s HER2+ therapeutic breast […]

The Nordic Health Summit Japan is a partnering and investor conference aimed at connecting Nordic healthcare innovations with Japanese investors […]

Meet with ExpreS2ion’s CMO, Mattis Flyvholm Ranthe, and VP of Preclinical Development, Mette Thorn, at 2022 ESMO Breast Cancer meeting. […]